Research

Robert Hromas, MD, Dean, Joe R. and Teresa Lozano Long School of Medicine and Vice President for Medical Affairs, UT Health San Antonio

A year of transformative progress

May 13, 2023

UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine Dean Robert Hromas, MD, identifies four areas of focus of the Mays Cancer Center in its quest to end cancer for communities in South Texas and beyond.



Sandeep Burma, PhD, Professor of Neurosurgery and Biochemistry and Structural Biology; Mays Family Foundation Distinguished Chair in Oncology; Vice Chair for Research, Department of Neurosurgery

The biology of cancer

May 13, 2023

Mays Cancer Center researchers are making significant strides in understanding risk factors and conditions that cause cancers to develop and progress and assessing impacts on the health and recovery of patients with cancer.



Ratna Vadlamudi, PhD, Professor and Vice Chair for Research, Department of Obstetrics and Gynecology

Promising compound kills range of hard-to-treat cancers

May 13, 2023

Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.



Mosaic image of hands touching

New discoveries in pediatric cancer research

May 13, 2023

The findings from recent research studies in pediatric cancer offer hope for drug development.



Mosaic art

Disparities discussed at San Antonio Breast Cancer Symposium

May 13, 2023

Researchers from the Mays Cancer Center at UT Health San Antonio presented results of multiple lines of study during the San Antonio Breast Cancer Symposium, operated in conjunction with the American Association of Cancer Research.



Researcher in lab

How COVID-19 vaccines affect patients with cancer

May 13, 2023

Mays Cancer Center researchers are studying how the immune system responds to the novel coronavirus vaccine in patients with cancer, and why many Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.